Welcome to our dedicated page for NewGenIvf Group news (Ticker: NIVF), a resource for investors and traders seeking the latest updates and insights on NewGenIvf Group stock.
NewGenIvf Group Limited (NASDAQ: NIVF) generates news across several distinct business lines, reflecting its evolution from a comprehensive fertility services provider in Asia into a diversified, tech-forward group. Company announcements highlight developments in reproductive health solutions, fertility technology, digital assets, and real estate projects.
In healthcare, NewGenIvf issues updates related to its fertility operations and its strategic pivot toward a technology-driven model. News items have covered acquisitions of advanced cytometry intellectual property and MicroSort sperm-sorting technology, which the company describes as central to building a licensing-based fertility technology platform.
Through its NewGenDigital division, the company frequently reports on digital asset and tokenization initiatives. Recent releases include plans and agreements to build a Solana (SOL) treasury, tokenize a private art collection, and act as worldwide tokenization agent for gold-backed assets associated with SAXA, Inc., earning percentage-based fees or commissions on tokenized asset values and sales.
NewGenIvf also issues news about real estate development via NewGenProperty, particularly a joint venture and joint development structure for a luxury project in the Beach District of Ras Al Khaimah in the UAE. Disclosures describe feasibility analyses, projected returns, and changes in profit allocation as the company exercises options under its joint venture agreement with BNW Real Estate Development LLC.
Investors following NIVF news will also see updates on financing arrangements, reverse stock splits, share repurchase programs, and a proposed reverse merger with SAXA, Inc. The Stock Titan NIVF news page aggregates these press releases and related coverage so readers can track how NewGenIvf’s fertility, digital asset, and real estate strategies develop over time.
NewGenIVF Group (NASDAQ: NIVF) filed its 2025 Annual Report on Form 20-F for the fiscal year ended December 31, 2025. The filing was made with the U.S. Securities and Exchange Commission on April 1, 2026.
The annual report is available on the company’s investor relations website for investor review and regulatory transparency.
NewGen (NASDAQ: NIVF) signed a Memorandum of Understanding with Women in Web3 Hong Kong on March 2, 2026 to co-launch a regional women’s health awareness and education campaign focused on health literacy, family planning, legacy design, and informed wellness decisions.
The collaboration will include talks, panels, community events, and co-branded materials leveraging NewGenSup insights into consumer wellness supplements to provide evidence-based, non-clinical resources within Hong Kong’s Web3 community.
NewGen (NASDAQ:NIVF) outlined a strategic transformation that produced US$28 million in net assets as of September 30, 2025 and a diversified, multi-sector portfolio.
Key moves include a July 2025 acquisition of cytometry IP valued at US$17.9 million, plans for a 2026 proprietary digital token, a live tokenized bond Commitment Campaign on Evident Capital’s Hong Kong platform, and a November 2025 $2 million share repurchase authorization.
NewGen (NASDAQ: NIVF) activated a Commitment Campaign on Evident Capital’s SFC-licensed Hong Kong tokenization platform on Feb 4, 2026, launching investor engagement for its inaugural tokenized real estate bond.
The campaign follows NewGen’s Jan 21, 2026 appointments and moved from announcement to live investor indications in under two weeks, targeting professional investors with a bond referencing the UAE Ras Al Khaimah residential project and using an institutional SPV, digital KYC, compliant primary distribution, and integrated secondary market rails as a repeatable financing template.
NewGen (Nasdaq: NIVF) announced it will execute its previously authorized share repurchase program of up to US$2 million through The Benchmark Company, LLC, a subsidiary of StoneX, using Benchmark’s institutional trading platform. The Board originally approved the program on November 10, 2025. Purchases will be made in the open market and may be subject to market conditions, share price, and trading volume. The program does not obligate NewGen to repurchase any specific number of shares and may be modified, suspended, or terminated at any time. Management said the program reflects confidence in NewGen’s long-term fundamentals and disciplined capital allocation.
NewGenIVF Group (NASDAQ: NIVF) appointed Web3 legal specialist Joshua Chu as Senior Counsel to lead tokenization and formally engaged Hong Kong SFC‑licensed Evident Capital to support an inaugural tokenized bond program of up to USD 30 million, targeted to close in Q1 2026, subject to market and regulatory conditions. The bonds reference real‑world assets including the Group’s UAE residential project near Ras Al Khaimah casino. NIVF aims for a non‑dilutive, debt‑style issuance intended to increase total assets and capital commitments by up to USD 28 million and to establish a repeatable, institution‑grade tokenization framework as a 2026 value catalyst.
NewGen (NASDAQ: NIVF) will exercise an option to convert its Ras Al Khaimah project from a Joint Venture to a Joint Development while retaining the SPV shareholdings. Under the new structure, NewGenProperty, a wholly owned subsidiary, will fund the project and receive 64% of net profits, with BNW retaining 36%. Based on BNW feasibility analysis, NewGen’s projected pre-tax profit rises from US$67 million to US$123 million (an 83% increase); project completion is targeted for 2028. The company plans to raise additional funds to support the conversion and financing. Ravenscroft & Schmierer reviewed the JVA and confirmed NewGen’s legal right to exercise the option. Presales will be permitted once 20% of the land purchase price is paid and non-financial escrow conditions are met.
NewGen (NASDAQ: NIVF) reported unaudited nine-month results for period ended September 30, 2025, showing a turnaround to $17.5M net income from a $0.416M net loss year‑ago.
Key drivers include a $23.44M non-cash bargain purchase gain from acquisitions (MicroSort and Nodexus IP), resulting in a $66.75 net book value per share. Total revenues were $3.3M (down from $4.2M), G&A rose to $5.7M, and other income improved to $23.2M.
Corporate actions: senior convertible note facility up to $28.8M, 13,000.23 SOL acquired, a $2M buyback authorization, and a 1-for-5 reverse stock split effective Dec 1, 2025.
NewGen (Nasdaq: NIVF) announced a Share Repurchase Program authorizing up to US$2 million of Class A ordinary shares to be repurchased over the next 24 months. The company said the authorized amount represents more than 50% of its current market capitalization and that repurchases will be executed in accordance with the Exchange Act, Rule 10b-18 and/or Rule 10b5-1 and the company’s insider trading policy.
The program may use open-market or privately negotiated transactions, will be funded from existing cash reserves, and can be adjusted, suspended or terminated by the Board at any time.
NewGenIvf Group (Nasdaq: NIVF) announced that subsidiary NewGenDigital signed an engagement letter effective October 30, 2025 to act as SAXA Inc.'s worldwide agent for tokenizing an initial US$100 million tranche of gold-backed assets.
The agreement is part one of a two-part transaction tied to a proposed reverse merger and includes an option to expand tokenization up to US$1 billion if the initial tranche completes. NewGenDigital will earn a 5% commission on assets sold, representing a potential revenue opportunity of about US$5 million. Services include SPV advisory, legal framework, blockchain implementation, and marketing.